This bond could be readily reduced by glutathione, which is typically present at an elevated concentration in the cytoplasm of cancer cells.310 Interesting results have also been achieved by the development of nanocarriers capable of passing through the blood brain barrier, for example, by the activation of a glucose transporter or by the conjugation of NPs with glycoproteins or lectins. The gene discussed is ART4; the disease is cancer.